Impact of aspirin use in the incidence of thromboembolic events after bioprosthesis replacement in patients with rheumatic disease

Documenti analoghi

• Evidence on the use of aspirin in the primary prevention of cardiovascular diseases
  di: Kayo Henrique Jardel Feitosa Sousa
  Pubblicazione: (2017)
• Evaluation of variables responsible for hospital mortality in patients with rheumatic heart disease undergoing double valve replacement
  di: André Maurício Souza Fernandes
  Pubblicazione: (2014)
• Anaemia in heart failure patients: the prevalence of haematinic deficiencies and the role of ACE inhibitors and aspirin doses as risk factors
  di: Kyrillos Guirguis
  Pubblicazione: (2019)
• Valvular heart disease during pregnancy: a clinical case and a literature review
  di: Diana Bužinskienė
  Pubblicazione: (2018)
• Long-term Mortality Predictors in Patients with Small Aortic Annulus Undergoing Aortic Valve Replacement with a 19- or 21-mm Bioprosthesis
  di: Jenny Lourdes Rivas de Oliveira
  Pubblicazione: (2016)